JOHN PRIBIS

John Pribis serves as a Senior Associate at Longwood Fund, a distinguished venture capital firm renowned for its strategic investments in the life sciences sector. In his pivotal role, Mr. Pribis is deeply involved in the entire investment lifecycle, from identifying promising early-stage companies to conducting rigorous due diligence and supporting portfolio companies as they grow. His work directly contributes to Longwood Fund's mission of fostering groundbreaking innovations that address critical unmet medical needs and improve patient outcomes.

At Longwood Fund, John Pribis's investment focus spans a broad spectrum of the life sciences. He actively seeks out opportunities in biotechnology, pharmaceuticals, medical devices, and diagnostics. His expertise lies in evaluating novel therapeutic platforms, disruptive technologies, and companies developing first-in-class or best-in-class treatments for a wide range of diseases. Mr. Pribis is particularly interested in ventures that demonstrate strong scientific fundamentals, clear clinical pathways, and significant market potential, aligning with Longwood Fund's strategy of building transformative companies.

Before joining Longwood Fund, John Pribis developed a robust background that prepared him for his current role in venture capital. His career journey has equipped him with a comprehensive understanding of both the scientific and business intricacies of the healthcare industry. This foundation allows him to effectively assess complex scientific data, evaluate market dynamics, and identify the key drivers of success for emerging life science companies. His analytical acumen and strategic insights are invaluable in navigating the rapidly evolving landscape of biotech innovation.

As a key member of the Longwood Fund team, John Pribis plays an instrumental role in shaping the firm's investment strategy and supporting its portfolio. While specific individual investments are often a collaborative effort at the fund level, Mr. Pribis has been involved in the evaluation and advancement of numerous companies that are poised to make significant contributions to medicine. His dedication to identifying and nurturing innovative life science ventures underscores Longwood Fund's commitment to driving progress in healthcare. Through his work, John Pribis helps ensure that promising scientific discoveries receive the capital and strategic guidance needed to translate into real-world solutions for patients worldwide.